Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frederic R Curtiss

Showing results (21-30 of 138) with videos related to

Pageof 14
Sort By:
Journal of Managed Care Pharmacy : JMCP|June 24, 2006
Heartburn in consumer-directed health care and the cost outcomes of therapeutic maximum allowable costFrederic R Curtiss
Journal of Managed Care Pharmacy : JMCP|February 3, 2007
False-positive versus true-positive drug-drug interactions with warfarinFrederic R Curtiss
Journal of Managed Care Pharmacy : JMCP|September 17, 2004
Value for money in disease management of benign prostatic hyperplasiaFrederic R Curtiss
Journal of Managed Care Pharmacy : JMCP|January 26, 2005
COPD-whose burden, how large, and what to do about it?Frederic R Curtiss
Journal of Managed Care Pharmacy : JMCP|January 15, 2004
3-tier drug benefit designs based on sound drug formulary principles will maximize favorable outcomesFrederic R Curtiss
Journal of Managed Care Pharmacy : JMCP|September 17, 2004
Who needs another clinical practice guideline?Frederic R Curtiss
Journal of Managed Care Pharmacy : JMCP|September 17, 2004
OTC omeprazole for your heartburn--enormous value-for-money opportunityFrederic R Curtiss
Journal of Managed Care Pharmacy : JMCP|March 16, 2005
Evidence-based medicine: beware of results from randomized controlled trials and research with administrative claims data the "new physician survey" sponsoredFrederic R Curtiss
Journal of Managed Care Pharmacy : JMCP|March 23, 2004
Clinical pharmacist interventions to bridge the quality chasm and methods necessary to hold quality improvement gainsFrederic R Curtiss
Journal of Managed Care Pharmacy : JMCP|November 14, 2003
Unraveling the effects of tier-copayment drug benefit designsFrederic R Curtiss
Pageof 14

Showing results (21-30 of 138) with videos related to

Sort By:
Pageof 14
Journal of Managed Care Pharmacy : JMCP|June 24, 2006
Heartburn in consumer-directed health care and the cost outcomes of therapeutic maximum allowable costFrederic R Curtiss
Journal of Managed Care Pharmacy : JMCP|February 3, 2007
False-positive versus true-positive drug-drug interactions with warfarinFrederic R Curtiss
Journal of Managed Care Pharmacy : JMCP|September 17, 2004
Value for money in disease management of benign prostatic hyperplasiaFrederic R Curtiss
Journal of Managed Care Pharmacy : JMCP|January 26, 2005
COPD-whose burden, how large, and what to do about it?Frederic R Curtiss
Journal of Managed Care Pharmacy : JMCP|January 15, 2004
3-tier drug benefit designs based on sound drug formulary principles will maximize favorable outcomesFrederic R Curtiss
Journal of Managed Care Pharmacy : JMCP|September 17, 2004
Who needs another clinical practice guideline?Frederic R Curtiss
Journal of Managed Care Pharmacy : JMCP|September 17, 2004
OTC omeprazole for your heartburn--enormous value-for-money opportunityFrederic R Curtiss
Journal of Managed Care Pharmacy : JMCP|March 16, 2005
Evidence-based medicine: beware of results from randomized controlled trials and research with administrative claims data the "new physician survey" sponsoredFrederic R Curtiss
Journal of Managed Care Pharmacy : JMCP|March 23, 2004
Clinical pharmacist interventions to bridge the quality chasm and methods necessary to hold quality improvement gainsFrederic R Curtiss
Journal of Managed Care Pharmacy : JMCP|November 14, 2003
Unraveling the effects of tier-copayment drug benefit designsFrederic R Curtiss
Pageof 14